Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gene predicts 4-fold increased stroke risk:

This article was originally published in Clinica

Executive Summary

A genetic abnormality that affects how the body processes cholesterol may increase the risk of stroke in young adults four-fold, according to a US study published in Stroke (June). A genetic polymorphism at position 192 of a gene called PON1 increased the risk of stoke by a factor of 4.10, reported study leader Barbara Voetsch, of the Whitaker Cardiovascular Institute at Boston University School of Medicine. The PON1 gene is involved in the production of the paraoxonase enzyme, which helps HDL cholesterol prevent the oxidation of LDL cholesterol. The PON1 polymorphism hold potential screening marker for stroke risk, she said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel